Status:
COMPLETED
New Strategies for Non-invasive Detection of Chronic Allograft Nephropathy
Lead Sponsor:
Virginia Commonwealth University
Collaborating Sponsors:
Hoffmann-La Roche
Conditions:
Chronic Rejection
Eligibility:
All Genders
18-70 years
Brief Summary
The purpose of this study is to help researchers find out more about a condition called "Chronic Allograft Nephropathy" (CAN). CAN is a complication that sometimes occurs after kidney transplantation ...
Detailed Description
We hypothesize that patients with CAN will manifest different patterns of gene expression profiling (compared with non-CAN controls), detectable in peripheral blood mononuclear cells (PBMCs) and urine...
Eligibility Criteria
Inclusion
- Received primary kidney transplant Diagnosis of Chronic Allograft Nephropathy Stable immunosuppression for one month prior to entry
Exclusion
- Serious comorbidity Pregnancy Retransplantation
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT00283348
Start Date
January 1 2006
End Date
December 1 2008
Last Update
March 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VCU Health System
Richmond, Virginia, United States, 23298